Cargando…
Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis
Objective: At the tissue level, disruption of the extracellular matrix network leads to irreversible cardiac fibrosis, which contributes to myocardial dysfunction. At the myocyte level, downregulation of beta-adrenoceptors (beta-AR) reduces adaptation to increased workload. The aim of our study was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145654/ https://www.ncbi.nlm.nih.gov/pubmed/37109251 http://dx.doi.org/10.3390/jcm12082915 |
_version_ | 1785034388826750976 |
---|---|
author | Petersen, Johannes Iqbal, Shahria Gedeon, Naomi Kloth, Benjamin Pecha, Simon Yildirim, Yalin Eschenhagen, Thomas Reichenspurner, Hermann Christ, Torsten Girdauskas, Evaldas |
author_facet | Petersen, Johannes Iqbal, Shahria Gedeon, Naomi Kloth, Benjamin Pecha, Simon Yildirim, Yalin Eschenhagen, Thomas Reichenspurner, Hermann Christ, Torsten Girdauskas, Evaldas |
author_sort | Petersen, Johannes |
collection | PubMed |
description | Objective: At the tissue level, disruption of the extracellular matrix network leads to irreversible cardiac fibrosis, which contributes to myocardial dysfunction. At the myocyte level, downregulation of beta-adrenoceptors (beta-AR) reduces adaptation to increased workload. The aim of our study was to analyse the correlation between myocardial fibrosis and beta-AR sensitivity in patients with aortic valve (AV) disease. Methods: A total of 92 consecutive patients who underwent elective AV surgery between 2017–2019 were included in our study (51 with aortic regurgitation (AR-group); 41 with aortic stenosis (AS-group) and left ventricular (LV) biopsies were obtained intraoperatively. In vitro force contractility testing was performed by measuring beta-AR sensitivity (−log EC(50)[ISO]). In parallel, a quantitative analysis of myocardial fibrosis burden was performed. Results: Mean age at the time of AV surgery was not statistically different in both groups (AR: 53.3 ± 15.3 years vs. AS: 58.7 ± 17.0 years; p = 0.116). The LV end-diastolic diameter was significantly enlarged in the AR-group when compared to the AS-group (59.4 ± 15.6 vs. 39.7 ± 21.2; p < 0.001). Analysis of beta-AR sensitivity (AR: −6.769 vs. AS: −6.659; p = 0.316) and myocardial fibrosis (AR: 8.9% vs. AS: 11.3%; p = 0.284) showed no significant differences between patients with AS and AR. There was no correlation between myocardial fibrosis and beta-AR sensitivity in the whole study cohort (R = 0.1987; p = 0.100) or in the AS-subgroup (R = 0.009; p = 0.960). However, significant correlation of fibrosis and beta-AR sensitivity was seen in AR-patients (R = 0.363; p = 0.023). Conclusion: More severe myocardial fibrosis was associated with reduced beta-AR sensitivity in patients presenting with AR but not with AS. Therefore, our results suggest that in patients with AR, cellular myocardial dysfunction is present and correlates with the extent of myocardial fibrosis in the myocardium. |
format | Online Article Text |
id | pubmed-10145654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101456542023-04-29 Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis Petersen, Johannes Iqbal, Shahria Gedeon, Naomi Kloth, Benjamin Pecha, Simon Yildirim, Yalin Eschenhagen, Thomas Reichenspurner, Hermann Christ, Torsten Girdauskas, Evaldas J Clin Med Article Objective: At the tissue level, disruption of the extracellular matrix network leads to irreversible cardiac fibrosis, which contributes to myocardial dysfunction. At the myocyte level, downregulation of beta-adrenoceptors (beta-AR) reduces adaptation to increased workload. The aim of our study was to analyse the correlation between myocardial fibrosis and beta-AR sensitivity in patients with aortic valve (AV) disease. Methods: A total of 92 consecutive patients who underwent elective AV surgery between 2017–2019 were included in our study (51 with aortic regurgitation (AR-group); 41 with aortic stenosis (AS-group) and left ventricular (LV) biopsies were obtained intraoperatively. In vitro force contractility testing was performed by measuring beta-AR sensitivity (−log EC(50)[ISO]). In parallel, a quantitative analysis of myocardial fibrosis burden was performed. Results: Mean age at the time of AV surgery was not statistically different in both groups (AR: 53.3 ± 15.3 years vs. AS: 58.7 ± 17.0 years; p = 0.116). The LV end-diastolic diameter was significantly enlarged in the AR-group when compared to the AS-group (59.4 ± 15.6 vs. 39.7 ± 21.2; p < 0.001). Analysis of beta-AR sensitivity (AR: −6.769 vs. AS: −6.659; p = 0.316) and myocardial fibrosis (AR: 8.9% vs. AS: 11.3%; p = 0.284) showed no significant differences between patients with AS and AR. There was no correlation between myocardial fibrosis and beta-AR sensitivity in the whole study cohort (R = 0.1987; p = 0.100) or in the AS-subgroup (R = 0.009; p = 0.960). However, significant correlation of fibrosis and beta-AR sensitivity was seen in AR-patients (R = 0.363; p = 0.023). Conclusion: More severe myocardial fibrosis was associated with reduced beta-AR sensitivity in patients presenting with AR but not with AS. Therefore, our results suggest that in patients with AR, cellular myocardial dysfunction is present and correlates with the extent of myocardial fibrosis in the myocardium. MDPI 2023-04-17 /pmc/articles/PMC10145654/ /pubmed/37109251 http://dx.doi.org/10.3390/jcm12082915 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Petersen, Johannes Iqbal, Shahria Gedeon, Naomi Kloth, Benjamin Pecha, Simon Yildirim, Yalin Eschenhagen, Thomas Reichenspurner, Hermann Christ, Torsten Girdauskas, Evaldas Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title | Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title_full | Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title_fullStr | Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title_full_unstemmed | Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title_short | Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis |
title_sort | valvular cardiomyopathy in aortic valve regurgitation correlates with myocardial fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145654/ https://www.ncbi.nlm.nih.gov/pubmed/37109251 http://dx.doi.org/10.3390/jcm12082915 |
work_keys_str_mv | AT petersenjohannes valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT iqbalshahria valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT gedeonnaomi valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT klothbenjamin valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT pechasimon valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT yildirimyalin valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT eschenhagenthomas valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT reichenspurnerhermann valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT christtorsten valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis AT girdauskasevaldas valvularcardiomyopathyinaorticvalveregurgitationcorrelateswithmyocardialfibrosis |